Human induced pluripotent stem cell-based platform for modeling cardiac ischemia
Abstract Ischemic heart disease is a major cause of death worldwide, and the only available therapy to salvage the tissue is reperfusion, which can initially cause further damage. Many therapeutics that have been promising in animal models have failed in human trials. Thus, functional human based ca...
Guardado en:
Autores principales: | Martta Häkli, Joose Kreutzer, Antti-Juhana Mäki, Hannu Välimäki, Henna Lappi, Heini Huhtala, Pasi Kallio, Katriina Aalto-Setälä, Mari Pekkanen-Mattila |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a4b8f6361442485f8e2228b64c1c0b3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
por: Marisa Ojala, et al.
Publicado: (2012) -
A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells.
por: Kristiina Rajala, et al.
Publicado: (2010) -
ABO and Rhesus Blood Groups in Acute Puumala Hantavirus Infection
por: Johanna Tietäväinen, et al.
Publicado: (2021) -
Director selection in agricultural cooperatives—The process and the roles in the Finnish context
por: Kari Huhtala, et al.
Publicado: (2020) -
Human pluripotent reprogramming with CRISPR activators
por: Jere Weltner, et al.
Publicado: (2018)